Authors' Reply to Gandjour: "Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines"

Newall, AT; Jit, M; Hutubessy, R; (2014) Authors' Reply to Gandjour: "Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines". PharmacoEconomics, 32 (12). p. 1247. ISSN 1170-7690 DOI: https://doi.org/10.1007/s40273-014-0232-0

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1007/s40273-014-0232-0

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar